These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16432708)

  • 21. Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis: a population-based study (DISS) in Sweden.
    Waernbaum I; Blohmé G; Ostman J; Sundkvist G; Eriksson JW; Arnqvist HJ; Bolinder J; Nyström L
    Diabetologia; 2006 Apr; 49(4):653-9. PubMed ID: 16447054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus.
    Laing SP; Swerdlow AJ; Slater SD; Botha JL; Burden AC; Waugh NR; Smith AW; Hill RD; Bingley PJ; Patterson CC; Qiao Z; Keen H
    Diabet Med; 1999 Jun; 16(6):466-71. PubMed ID: 10391393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
    Rawshani A; Rawshani A; Franzén S; Eliasson B; Svensson AM; Miftaraj M; McGuire DK; Sattar N; Rosengren A; Gudbjörnsdottir S
    N Engl J Med; 2017 Apr; 376(15):1407-1418. PubMed ID: 28402770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus.
    Laing SP; Swerdlow AJ; Slater SD; Botha JL; Burden AC; Waugh NR; Smith AW; Hill RD; Bingley PJ; Patterson CC; Qiao Z; Keen H
    Diabet Med; 1999 Jun; 16(6):459-65. PubMed ID: 10391392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cause-specific and total mortality in the Canterbury (New Zealand) insulin-treated Diabetic Registry population: a 15-year follow-up study.
    Florkowski CM; Scott RS; Graham PJ; Han DY; Moir CL
    Diabet Med; 2003 Mar; 20(3):191-7. PubMed ID: 12675662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. All-cause mortality in a nationwide cohort of childhood-onset diabetes in Norway 1973-2013.
    Gagnum V; Stene LC; Sandvik L; Fagerland MW; Njølstad PR; Joner G; Skrivarhaug T
    Diabetologia; 2015 Aug; 58(8):1779-86. PubMed ID: 25972232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls.
    Bannister CA; Holden SE; Jenkins-Jones S; Morgan CL; Halcox JP; Schernthaner G; Mukherjee J; Currie CJ
    Diabetes Obes Metab; 2014 Nov; 16(11):1165-73. PubMed ID: 25041462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. All-cause mortality in insulin-treated diabetic patients: a 20-year follow-up.
    Dawson SI; Willis J; Florkowski CM; Scott RS
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e6-9. PubMed ID: 18329123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mortality rates due to diabetes in a selected urban south Indian population--the Chennai Urban Population Study [CUPS--16].
    Mohan V; Shanthirani CS; Deepa M; Deepa R; Unnikrishnan RI; Datta M
    J Assoc Physicians India; 2006 Feb; 54():113-7. PubMed ID: 16715613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.
    Pavkov ME; Bennett PH; Knowler WC; Krakoff J; Sievers ML; Nelson RG
    JAMA; 2006 Jul; 296(4):421-6. PubMed ID: 16868300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. All-cause mortality and its risk factors among type 1 and type 2 diabetes mellitus in a country facing diabetes epidemic.
    Al-Rubeaan K; Youssef AM; Ibrahim HM; Al-Sharqawi AH; AlQumaidi H; AlNaqeb D; Aburisheh KH
    Diabetes Res Clin Pract; 2016 Aug; 118():130-9. PubMed ID: 27371778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated risk of death and major cardiovascular events in subjects with newly diagnosed diabetes: findings from an administrative database.
    Monesi L; Tettamanti M; Cortesi L; Baviera M; Marzona I; Avanzini F; Monesi G; Nobili A; Riva E; Fortino I; Bortolotti A; Fontana G; Merlino L; Trevisan R; Roncaglioni MC
    Nutr Metab Cardiovasc Dis; 2014 Mar; 24(3):263-70. PubMed ID: 24418374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using The Health Improvement Network (THIN).
    Weber DR; Haynes K; Leonard MB; Willi SM; Denburg MR
    Diabetes Care; 2015 Oct; 38(10):1913-20. PubMed ID: 26216874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of diabetic foot syndrome and its risk factors in the UK.
    Lauterbach S; Kostev K; Kohlmann T
    J Wound Care; 2010 Aug; 19(8):333-7. PubMed ID: 20852505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer.
    Holden SE; Jenkins-Jones S; Morgan CL; Schernthaner G; Currie CJ
    Diabetes Obes Metab; 2015 Apr; 17(4):350-62. PubMed ID: 25399739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy.
    Tarnow L; Hildebrandt P; Hansen BV; Borch-Johnsen K; Parving HH
    Diabetologia; 2005 Jan; 48(1):149-55. PubMed ID: 15616804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excess Mortality among Persons with Type 2 Diabetes.
    Tancredi M; Rosengren A; Svensson AM; Kosiborod M; Pivodic A; Gudbjörnsdottir S; Wedel H; Clements M; Dahlqvist S; Lind M
    N Engl J Med; 2015 Oct; 373(18):1720-32. PubMed ID: 26510021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term mortality and retinopathy in type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2010 May; 88 Thesis1():1-14. PubMed ID: 20500731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purchase of antidepressant agents by patients with type 1 diabetes is associated with increased mortality rates in women but not in men.
    Ahola AJ; Harjutsalo V; Saraheimo M; Forsblom C; Groop PH;
    Diabetologia; 2012 Jan; 55(1):73-9. PubMed ID: 22033620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database.
    Taylor KS; Heneghan CJ; Farmer AJ; Fuller AM; Adler AI; Aronson JK; Stevens RJ
    Diabetes Care; 2013 Aug; 36(8):2366-71. PubMed ID: 23435157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.